BioSpace News Archive

Deals

RVL Pharmaceuticals plc Announces $5 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules

RVL Pharmaceuticals plc today announced that it has entered into definitive agreements for the purchase and sale of 11,870,846 of its ordinary shares.

August 16, 2023
·
5 min read
Biotech Beach

Bionano Laboratories Receives College of American Pathologists (CAP) Accreditation for its Clinical Laboratory

Bionano Laboratories, a laboratory services business of Bionano Genomics, Inc. (Nasdaq: BNGO), today announced that it has received Laboratory Accreditation from the College of American Pathologists (CAP) for its Clinical Laboratory Improvement Amendments (CLIA)-certified reference lab.

August 16, 2023
·
5 min read
Business

Baudax Bio Reports Second Quarter 2023 Financial Results and Provides Business Update

Baudax Bio, Inc. today announced results for the three and six months ended June 30, 2023 and provided a business update.

August 16, 2023
·
17 min read
Drug Development

QSAM Biosciences Provides Update to Shareholders on Phase 1 Progress and Preliminary Clinical Data

QSAM Biosciences Inc. today issued the following letter to its shareholders.

August 16, 2023
·
10 min read
Business

CU Innovations and Core Bio Announce Strategic Partnership

Core Biotherapeutics has entered into a collaboration with the University of Colorado Anschutz Medical Campus (CU Anschutz) to expand the benefits of their therapeutic approach to Acute Myeloid Leukemia (AML) patients.

August 16, 2023
·
4 min read
Pharm Country

Sectra Signs Enterprise Imaging Contract With One of the Larger Multi-Region Healthcare Systems in the US

International medical imaging IT and cybersecurity company Sectra will provide Sectra One Cloud, its enterprise imaging cloud subscription service for diagnostic imaging, to a US based health system serving a multi-million strong patient community.

August 16, 2023
·
2 min read
Business

VintaBio Names Jennifer Kingsley Chief Commercial Officer

VintaBio named Jennifer Kingsley as its first Chief Commercial Officer to develop and implement the company’s commercial strategy.

August 16, 2023
·
3 min read
FDA

Artiva Biotherapeutics Announces FDA Clearance of IND for AlloNK® Cell Therapy Candidate in Combination with Rituximab in Lupus Nephritis

Artiva Biotherapeutics Announces FDA Clearance of IND for AlloNK ® Cell Therapy Candidate in Combination with Rituximab in Lupus Nephritis.

August 16, 2023
·
6 min read
Business

HALO Precision Diagnostics Appoints John Craighead as Chief Operating Officer and Chief Financial Officer

HALO Precision Diagnostics (“HALO”), the leader in early disease detection using precision diagnostics, today announced the appointment of John Craighead, Ph.D., as chief operating officer and chief financial officer.

August 16, 2023
·
2 min read
Business

Empress Therapeutics Appoints Dawn Thompson, Ph.D., Senior Vice President, Head of Platform Development

Empress Therapeutics Appoints Dawn Thompson, Ph.D., Senior Vice President, Head of Platform Development.

August 16, 2023
·
3 min read